LINE vs LLY · rev $5.34B vs P/E 39, rev $65.18B
Lineage, Inc. Common Stock (LINE) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
Lineage, Inc. Common Stock (LINE) is a reit - industrial company listed on NASDAQ.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Latest reported LINE revenue for 2024-12-31 was $5.34B. Net income was -$751.0M. Revenue was down 0.0% from 2023-12-31 to 2024-12-31. LINE currently screens at market cap $10.41B.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
LINE currently screens at market cap $10.41B. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the LINE and LLY stock pages for the full models.
Not investment advice.